So Mr market values us at 4.3c currently given what the Co has announced in the last 2 months or so, interesting:
04/07 - New Study validated pain detection sp 2.5c
19/07 - Epat secures TGA and CE approval sp 3.5c
24/07 - Nviso agrees perpetual global license sp 4.2c
15/08 - Clinical study published in Alzheimers disease journal sp 5.6c
07/09 - Core strategic agreement with DSA sp 7.4c
18/09 - 3.75 mill raised through Insto,family Office and SI placement, funds to be used for commercial roll out in Q4 and FDA approvals sp 5.6c
26/09 - Epat to accelerate commercialisation at Alzheimers conference held mid Oct sp 4.3c
Currently sp 4.3c and approx a full 360 to where we were 2 months ago.
EPT Chart, page-823
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 546666 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 129158 | 2 |
View Market Depth
| Last trade - 16.33pm 27/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable